Abstract
The biological safety of biomaterials used for implantable medical devices is usually determined by a series of standard tests that assess the effects that extractable substances have on cells in vitro and in simple short term animal studies. To use these tests to determine the suitability of materials for tissue engineering templates is inappropriate. This short essay discusses the issues that are involved.
Similar content being viewed by others
References
International Standards Organization, biological evaluation of medical devices, part 1 evaluation and testing, ISO 10993: 2003.
Williams DF. The biomaterials conundrum in tissue engineering. Tissue Eng Part A. 2014;20(7–8):1129–31.
Williams DF. To engineer is to create: the link between engineering and regeneration. Trends Biotechnol. 2006;24:4–8.
Williams DF. On the mechanisms of biocompatibility. Biomaterials. 2008;29(20):2941–53.
Williams DF. There is no such thing as a biocompatible material. Biomaterials. 2014;35:10009–14.
Williams DF. Essential Biomaterials Science. Cambridge: Cambridge University Press; 2014. p. 670.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Williams, D.F. Regulatory biocompatibility requirements for biomaterials used in regenerative medicine. J Mater Sci: Mater Med 26, 89 (2015). https://doi.org/10.1007/s10856-015-5421-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10856-015-5421-7